ENG Pellets

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: A biodegradable implant that can achieve 18 months duration using etonogestrel /cholesterol fused pellets.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2015

Status Details:
  • Builds upon earlier work on NET Pellets with Anterion Therapeutics.

Download Product Report